Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
JAK
>>
Phase 3
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
6
12
18
24
30
36
42
48
54
60
itacitinib
(INCB039110) / Incyte
Vonjo
(pacritinib) / SOBI
Litfulo
(ritlecitinib) / Pfizer
Inrebic
(fedratinib) / BMS
jaktinib
/ Suzhou Zelgen
Smyraf
(peficitinib) / Astellas, Maruho
ivarmacitinib
(SHR0302) / Jiangsu Hengrui Pharma, Arcutis
Corectim
(delgocitinib) / LEO Pharma
deuruxolitinib
(CTP-543) / Sun Pharma
brepocitinib
(PF-06700841) / Priovant Therap
povorcitinib
(INCB54707) / Incyte
Ojjaara
(momelotinib) / GSK
lestaurtinib
(CEP-701) / Teva, Kyowa Kirin
TAK-279
/ Takeda
Augtyro
(repotrectinib) / BMS
LNK01001
/ Lynk Pharmaceuticals
izencitinib
(TD-1473) / Theravance Biopharma
TLL018
/ Highlightll Pharma
tinengotinib
(TT-00420) / TransThera Biosci
decernotinib
(VX-509) / Vertex
